Kwang Dong Pharmaceutical Co., Ltd. (009290.KS)
KSE · KRW · Consumer Defensive · Packaged Foods
₩6,360 (-1.40%) as of
Key statistics
- Market cap
- 316.11B
- Dividend yield
- 1.55%
- 52-week range
- 5,150.00 – 12,800.00
- Beta
- 0.35
- Revenue (TTM)
- 1.71T
- Profit margin
- 1.28%
- Volume
- 122.21k
About Kwang Dong Pharmaceutical Co., Ltd.
Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins. The company also offers supplements for low content vitamin, mineral or vital energy substance and quasi drugs. In addition, it provides blackberry, ginger lonicerae flos, vita gold, and red ginseng gold drinks, as well as offers water, mixed drinks, tea drinks, and other drinks; and traditional health foods. The company offers its products through operation of TV, radio, and print advertising. Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Headquarters
- Seoul, South Korea
- Employees
- 1,001
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.